We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04088058
Recruitment Status : Unknown
Verified March 2020 by Gwo Xi Stem Cell Applied Technology Co., Ltd..
Recruitment status was:  Recruiting
First Posted : September 12, 2019
Last Update Posted : March 5, 2020
Information provided by (Responsible Party):
Gwo Xi Stem Cell Applied Technology Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 31, 2021
Estimated Study Completion Date : June 30, 2022